Skip to main content
Clinical Trials/DRKS00029012
DRKS00029012
Recruiting
Not Applicable

Prospective investigation of the morphology-based risk score for colon carcinoma stratification - MBR

niversitätsklinikum Augsburg0 sites300 target enrollmentAugust 3, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C18
Sponsor
niversitätsklinikum Augsburg
Enrollment
300
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 3, 2022
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Augsburg

Eligibility Criteria

Inclusion Criteria

  • (1\) Initial diagnosis of untreated colon carcinoma (NOS), UICC stage I – II, R0
  • (2\) Treatment in the University Hospital Augsburg or in one of the partner hospitals
  • (3\) Availability of sufficient tumor material (paraffin block and/or fresh tissue) or sections
  • (4\) Written consent from the patient to participate in the study

Exclusion Criteria

  • (1\) Neoadjuvant therapy of colon carcinoma
  • (2\) Patients unable to consent
  • (3\) Insufficient understanding of the German language
  • (4\) Patients with chronic inflammatory bowel disease
  • (5\) Patients with hereditary colorectal cancer syndromes (such as Lynch syndrome, familial adenomatous polyposis)

Outcomes

Primary Outcomes

Not specified

Similar Trials